Zobrazeno 1 - 10 of 13 pro vyhledávání: '"Marta Gómez Nuñez"'
1
Use of eltrombopag for patients 65 years old or older with immune thrombocytopenia
Autor: Isidro Jarque, Erik de Cabo, Marta Gómez-Nuñez, Elsa López-Ansoar, Gloria Pérez-Rus, María Yera Cobo, Fernando Fernández-Fuertes, Germán Perdomo, Pável E Olivera, María Jesús Peñarrubia, Estefanía Bolaños, María Paz Martínez Badas, Isabel Caparrós, Blanca Sanchez-Gonzalez, Angeles Fernández-Rodríguez, Luis Javier García-Frade, Tomás José González-López, Carmen Fernández-Miñano, Jose Angel Hernandez-Rivas, Silvia Bernat, Inmaculada Soto, Violeta Martínez-Robles, Cristina Pascual
Publikováno v: Digital.CSIC. Repositorio Institucional del CSIC
instname
Repositorio Institucional de la Universidad de Burgos (RIUBU)
Universidad de Almería
EUROPEAN JOURNAL OF HAEMATOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
r-FISABIO. Repositorio Institucional de Producción Científica
[Background]: Eltrombopag is useful for immune thrombocytopenia (ITP). However, results of clinical trials may not accurately mirror clinical practice reality. Here we evaluated eltrombopag for primary and secondary ITP in our ≥65‐year‐old popu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db91a8b053c596692384d95d1bbdd342
http://hdl.handle.net/10261/220424
Zobrazit plný text záznamu
2
Akademický článek
Non-natural and photo-reactive amino acids as biochemical probes of immune function.
Autor: Marta Gómez-Nuñez, Kurtis J Haro, Tao Dao, Deming Chau, Annie Won, Sindy Escobar-Alvarez, Victoriya Zakhaleva, Tatyana Korontsvit, David Y Gin, David A Scheinberg
Publikováno v: PLoS ONE, Vol 3, Iss 12, p e3938 (2008)
Wilms tumor protein (WT1) is a transcription factor selectively overexpressed in leukemias and cancers; clinical trials are underway that use altered WT1 peptide sequences as vaccines. Here we report a strategy to study peptide-MHC interactions by in
Externí odkaz: https://doaj.org/article/30d4d05cd0184de5a54cb2a7878f3a05
Zobrazit plný text záznamu
4
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia
Autor: María Perera, Montserrat Cortés, Erika Coria, Miguel Angel Fuertes-Palacio, Laura Solán, Isabel Caparrós, Inés Valcarce, Isidro Jarque, Carlos Aguilar, R. Jiménez, Pilar Galan, Silvia Bernat, Tomás José González-López, Pável E Olivera, Mónica Martín-Salces, Adriana Sainz, María Carmen Arratibel, María Paz Martínez-Badas, Maria Eva Mingot-Castellano, Manuel González-Silva, Fernando Fernández-Fuertes, Rafael Feito Alonso, Erik de Cabo, Juan Andrés Vázquez-Paganini, Angeles Fernández-Rodríguez, Susana Pérez-Crespo, Paola Beneit, Carmen Fernández-Miñano, Rosa Fisac, Carmen de Cos, Maria José Cortti, Violeta Martínez-Robles, Jose Angel Hernandez-Rivas, Alberto Casaus, Armando Luaña, Isabel Gutierrez-Jomarrón, Arancha Alonso, Cristina Fernández-Canal, María Teresa Álvarez-Román, María Jesús Peñarrubia, Javier García-Frade, Marcio M Andrade, José Ramón González-Porras, Marta Gómez-Nuñez, María Calbacho, Gloria Pérez-Rus, Cristina Pascual, Blanca Sanchez-Gonzalez
Publikováno v: American Journal of Hematology. 90:E40-E43
Eltrombopag is effective and safe in immune thrombocytopenia (ITP). Some patients may sustain their platelet response when treatment is withdrawn but the frequency of this phenomenon is unknown. We retrospectively evaluated 260 adult primary ITP pati
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::51bdd0e8fe6218ff5b4f6f1ed793dbab
https://doi.org/10.1002/ajh.23900
Zobrazit plný text záznamu
6
Peptide binding motif predictive algorithms correspond with experimental binding of leukemia vaccine candidate peptides to HLA-A*0201 molecules
Autor: Javier Pinilla-Ibarz, Rena J. May, Jaspreet Singh Jaggi, Marta Gómez-Nuñez, Mary Pao, Tao Dao, David A. Scheinberg
Publikováno v: Leukemia Research. 30:1293-1298
The ability to reliably identify the peptides that can bind to MHC molecules is of practical importance for rapid vaccine development. Several computer-based prediction methods have been applied to study the interaction of MHC class I/peptide binding
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d6f0daebc21eabb3d446a93909e2e33
https://doi.org/10.1016/j.leukres.2006.02.010
Zobrazit plný text záznamu
7
Non-natural and photo-reactive amino acids as biochemical probes of immune function
Autor: Sindy Escobar-Alvarez, Kurtis J. Haro, Annie Won, David A. Scheinberg, Tatyana Korontsvit, Marta Gómez-Nuñez, David Y. Gin, Tao Dao, Victoriya Zakhaleva, Deming Chau
Publikováno v: PLoS ONE, Vol 3, Iss 12, p e3938 (2008)
PLoS ONE
Wilms tumor protein (WT1) is a transcription factor selectively overexpressed in leukemias and cancers; clinical trials are underway that use altered WT1 peptide sequences as vaccines. Here we report a strategy to study peptide-MHC interactions by in
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e153ec0e099ffc39ce78554f8430e62c
http://europepmc.org/articles/PMC2592539?pdf=render
Zobrazit plný text záznamu
10
Natural killer cells license dendritic cell cross-presentation of B lymphoma cell--associated antigens
Autor: Jaspreet Singh Jaggi, David A. Scheinberg, Christophe Antczak, Victoriya Zakhaleva, Barry J. Kappel, Tao Dao, Marta Gómez-Nuñez, Tatyana Korontsvit
Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research. 11(24 Pt 1)
Purpose: Presentation of exogenous antigen by MHC class I molecules, or cross-presentation, is a property of dendritic cells, which is considered crucial for the priming of cytotoxic T-cell response to tumor antigens. However, the precise mechanisms
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c1f44eb66de81980391a55fde4e0a1a
https://pubmed.ncbi.nlm.nih.gov/16361564
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje